SCHEMBL4312845

SCHEMBL4312845

Nc1cn(-c2ccccc2)nc1NC(=O)c1cc2ccc(C(F)c3nnc(-c4ccccc4)o3)cc2s1

nearest known ligand 0.36

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
S1PR3 Q99500 1/20 0.36
ADORA3 P0DMS8 4/20 0.34
HDAC1 Q13547 3/20 0.34
NPSR1 Q6W5P4 2/20 0.34
HDAC2 Q92769 1/20 0.34
USP2 O75604 1/20 0.34
LMNA P02545 1/20 0.34
HSD17B10 Q99714 1/20 0.34
KDR P35968 3/20 0.33
KDM4E B2RXH2 1/20 0.33
CRHBP P24387 1/20 0.33
MAPK1 P28482 1/20 0.33
CRHR2 Q13324 1/20 0.33
SAE1 Q9UBE0 1/20 0.33
UBA2 Q9UBT2 1/20 0.33
HDAC6 Q9UBN7 2/20 0.33
PTGS2 P35354 2/20 0.32
DGAT1 O75907 1/20 0.32
PDPK1 O15530 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13950309 0.84 ADORA3 (0.41) S1PR3ADORA3HDAC1HDAC2LMNA
SCHEMBL3570560 0.79 S1PR3 (0.44) S1PR3HDAC1NPSR1LMNAKDM4E
SCHEMBL3578064 0.77 HDAC1 (0.42) ADORA3HDAC1HDAC2
SCHEMBL2440113 0.77 TMIGD3 (0.49) ADORA3HDAC1HDAC2HDAC6
SCHEMBL3576539 0.73 TP53 (0.45) S1PR3USP2HSD17B10KDM4E
SCHEMBL2437475 0.72 LMNA (0.42) ADORA3LMNAKDM4EMAPK1
SCHEMBL3576151 0.70 HDAC1 (0.57) ADORA3HDAC1HDAC2HDAC6
SCHEMBL8233506 0.68 ADORA3 (0.44) ADORA3HDAC1HDAC2LMNAKDM4E
SCHEMBL2433915 0.66 HDAC6 (0.60) ADORA3HDAC1NPSR1USP2LMNA
SCHEMBL3566006 0.66 PPARD (0.39) LMNAHSD17B10KDM4EMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090082308-A1 Benzothiophene derivatives MERCK SHARP & DOHME LLC 2009-03-26 US disclosed
US-20090012075-A1 Fluorinated Arylamide Derivatives MERCK SHARP & DOHME CORP. 2009-01-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090012075-A1 Fluorinated Arylamide Derivatives HDAC5, AADAC, HDAC6 S1PR3 1352/4885ADORA3 3058/4885HDAC1 4/4885
US-20090082308-A1 Benzothiophene derivatives BRDT, HDAC5, BRPF3 S1PR3 1993/4885ADORA3 3980/4885HDAC1 4/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.